International Congress Barcelona 2013

Citations should be made in the following way: Authors. Title. Eur Respir J 2013; 42: Suppl. 57, abstract number.

Oral Presentation
Chairs: A. Torres (Barcelona, Spain), D. Bouros (Alexandroupolis, Greece)

LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus E. J. Swindle, C. Blume, P. Collins, D. D. Metcalfe, S. T. Holgate, D. E. Davies (Southampton, United Kingdom; Bethesda, United States Of America)
Simplifying IDSA/ATS pneumonia guidelines W. Salih, J. Chalmers, S. Schembri (Dundee, United Kingdom)
TLR7 gene deficiency and early-life pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice G. Kaiko, Z. Loh, K. Spann, J. Lynch, A. Lalwani, S. Davidson, P. Foster, S. Phipps (Newcastle, Brisbane, Australia)
Vapendavir significantly improves upper respiratory symptoms of naturally acquired rhinovirus infection in asthmatic adults: Results of a phase 2 clinical trial J. Matz (Baltimore, United States Of America)
Type I interferons and IL-15 regulate antiviral cellular responses to rhinovirus infection A. Jayaraman, S. Johnston, N. Bartlett (London, United Kingdom)
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection C. Bellinghausen, E. V. Beuken, E. F. M. Wouters, G. G. U. Rohde, F. R. Stassen (Maastricht, Netherlands)
The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial A. Averyanov, E. Andrianova (Moscow, Russian Federation)